Main Content

Press Release
WKR: ELEKTA TO DELIVER FIRST LEKSELL GAMMA KNIFE� UNIT TO RUSSIA

ELEKTA TO DELIVER FIRST LEKSELLGAMMA KNIFE� UNIT TO RUSSIA

Burdenko NeurosurgicalInstitute in Moscow will add non-invasive brain surgery to itsrange of advanced treatment methods

Recently, Elekta finalized thecontract with Finance Leasing Company (Moscow, Russia) andNeurosurgical Business Center (NBC) for Burdenko NeurosurgicalInstitute to deliver Leksell Gamma Knife�, the goldstandard equipment for non-invasive Gamma Knife�surgery. This Leksell Gamma Knife� unit is the firstto be installed in Russia, serving a previously unmet need fornon-invasive treatment of small to medium size intracraniallesions.

"We are very excited aboutthe prospect of adding Leksell Gamma Knife� to ouradvanced treatment methods here at Burdenko", says Dr.Nikolay Alexandrovich Konovalov, Director of the Institute."Continuing our tradition of being at the forefront ofmicrosurgery and minimally invasive treatments, the addition ofGamma Knife� surgery will provide us with a method totreat a variety of brain tumors, vascular malformations andfunctional diseases that will be of great benefit to our patients.The non-invasive technique of Gamma Knife� surgeryoffers important benefits. We are in high demand for thesetreatments and I expect a high patient volume on our LeksellGamma Knife� unit", Dr Konovalov concludes.

"Gamma Knife�surgery revolutionized the treatment of brain disorders when itwas introduced over thirty years ago. Today, the potential forits use and the benefits that it brings are bigger than ever. Itis with great pride that we now are going to supply the firstLeksell Gamma Knife� unit to Russia", saysThomas Meyer von der Twer, Director of European sales ofneurosurgery products at Elekta, and continues: "It is alsoan honor to welcome the esteemed Dr Konovalov and his colleaguesto Leksell Gamma Knife Society and to the sharing of experiences,new results and solutions to clinical problems that to this dayhas produced more than 2,000 scientific papers, documenting theresults of various treatments with Leksell Gamma Knife�".

To date, well over 250,000patients around the world have been treated with Leksell GammaKnife�, and each year more than 30,000 new patientsare treated at the close to 200 units installed around the world.

The total payment for the LeksellGamma Knife� unit to Burdenko Neurosurgical Institutewill amount to 3,8 MEUR. The order was booked by Elekta inFebruary.

 

For further information, pleasecontact:
International: Peter Ejemyr, Group VP CorporateCommunications, Elekta AB (publ),
Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
United States: Lars Jonsteg, VP Investor Relations North America,Elekta, USA
Phone: +1 770-670-2419, e-mail: lars.jonsteg@elekta.com

Elekta is a world-leadingsupplier of advanced and innovative radiation oncology andneurosurgery solutions and services for precise treatment ofcancer and brain disorders. Elekta's solutions are clinicallyeffective, cost efficient and gentle to the patient.

For additional information aboutElekta, please visit www.elekta.com


This information was brought to you by Waymaker http://www.waymaker.net

The following files are available for download: